Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Environmental Health and Preventive Medicine
Published in: Environmental Health and Preventive Medicine 2/2014

01-03-2014 | Regular Article

Species and inter-individual differences in metabolic capacity of di(2-ethylhexyl)phthalate (DEHP) between human and mouse livers

Authors: Yuki Ito, Michihiro Kamijima, Chie Hasegawa, Masahiro Tagawa, Toshio Kawai, Mio Miyake, Yumi Hayashi, Hisao Naito, Tamie Nakajima

Published in: Environmental Health and Preventive Medicine | Issue 2/2014

Login to get access

Abstract

Objectives

This study was conducted to assess inter-species and inter-individual differences in the metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans and mice.

Methods

The activities of four DEHP-metabolizing enzymes [lipase, UDP-glucuronocyltransferase (UGT), alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH)] were measured in the livers of 38 human subjects of various ages and in eight 129/Sv male mice.

Results

Microsomal lipase activity was significantly lower in humans than in mice. The V max/K m value in humans was one-seventh of that in mice, microsomal UGT activity in humans was a sixth of that in mice, and cytosolic ALDH activity for 2-ethylhexanal in humans was one-half of that in mice. In contrast, ADH activity for 2-ethylhexanol was twofold higher in humans than in mice. The total amount of DEHP urinary metabolites and the concentration of mono(2-ethylhexyl)phthalate (MEHP) were much higher in intact mice than in the U.S. general population based on data reported elsewhere, regardless of the similar estimated DEHP intake between these mice and the human reference population. However, mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP) and mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) levels were higher in the latter than in the former. Of note, inter-subject variability in the activities of all enzymes measured was 10–26-fold.

Conclusion

The inter-individual variation in the metabolism of DEHP in humans may be greater than the difference between mice and humans (inter-species variation), and both may affects the risk assessment of DEHP.
Literature
1.
Center for Disease Control and Prevention (CDC). The Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables. 2012. CDC, Atlanta.
2.
Albro PW, Lavenhar SR. Metabolism of di(2-ethylhexyl)phthalate. Drug Metab Rev. 1989;21(1):13–34.PubMedCrossRef
3.
Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure—an update and latest results. Int J Androl. 2006;29(1):155–65 (discussion 181–5).PubMedCrossRef
4.
Ito Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, Nakajima T. Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl)phthalate (DEHP) treatment in mice and rats, but not marmosets. Arch Toxicol. 2007;81(3):219–26.PubMedCrossRef
5.
Ito Y, Yokota H, Wang R, Yamanoshita O, Ichihara G, Wang H, et al. Species differences in the metabolism of di(2-ethylhexyl)phthalate (DEHP) in several organs of mice, rats, and marmosets. Arch Toxicol. 2005;79(3):147–54.PubMedCrossRef
6.
Kavlock R, Barr D, Boekelheide K, Breslin W, Breysse P, Chapin R, et al. NTP-CERHR expert panel update on the reproductive and developmental toxicity of di(2-ethylhexyl)phthalate. Reprod Toxicol. 2006;22(3):291–399.PubMedCrossRef
7.
Choi K, Joo H, Campbell JL Jr, Clewell RA, Andersen ME, Clewell HJ 3rd. In vitro metabolism of di(2-ethylhexyl)phthalate (DEHP) by various tissues and cytochrome P450s of human and rat. Toxicol In Vitro. 2012;26(2):315–22.PubMedCrossRef
8.
Wang RS, Nakajima T, Honma T. Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology. 1999;132(1):9–18.PubMedCrossRef
9.
Hayashi Y, Ito Y, Yanagiba Y, Kamijima M, Naito H, Nakajima T. Differences in metabolite burden of di(2-ethylhexyl)phthalate in pregnant and postpartum dams and their offspring in relation to drug-metabolizing enzymes in mice. Arch Toxicol. 2012;86(4):563–9.PubMedCrossRef
10.
Kawai T, Mizunuma K, Yasugi T, Uchida Y, Ikeda M. The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane. Int Arch Occup Environ Health. 1990;62(5):403–8.PubMedCrossRef
11.
Finkelstein MM, Verma DK. Exposure estimation in the presence of nondetectable values: another look. AIHAJ. 2001;62(2):195–8.PubMed
12.
Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008;4(6):697–720.PubMedCentralPubMedCrossRef
13.
Goedde HW, Agarwal DP, Harada S, Rothhammer F, Whittaker JO, Lisker R. Aldehyde dehydrogenase polymorphism in North American, South American, and Mexican Indian populations. Am J Hum Genet. 1986;38(3):395–9.PubMedCentralPubMed
14.
Goedde HW, Agarwal DP, Harada S, Meier-Tackmann D, Ruofu D, Bienzle U, et al. Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity. Am J Hum Genet. 1983;35(4):769–72.PubMedCentralPubMed
15.
Spence JP, Liang T, Eriksson CJ, Taylor RE, Wall TL, Ehlers CL, et al. Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol Clin Exp Res. 2003;27(9):1389–94.PubMedCrossRef
16.
Joo H, Choi K, Grimes J, O’Connell T, Clewell R, Campbell J, Clewell H. Phase II biotransformation of di(2-ethylhexyl)phthalate in human and rat. In: 50th Annu Meet Society of Toxicology. 2011. Article no. 1824.
17.
Mehlotra RK, Bockarie MJ, Zimmerman PA. Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Eur J Clin Pharmacol. 2007;63(1):1–8.PubMedCentralPubMedCrossRef
18.
Innocenti F, Liu W, Fackenthal D, Ramirez J, Chen P, Ye X, et al. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenetics Genomics. 2008;18(8):683–97.PubMedCentralPubMedCrossRef
19.
Girard H, Court MH, Bernard O, Fortier LC, Villeneuve L, Hao Q, et al. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics. 2004;14(8):501–15.PubMedCrossRef
20.
Olson KC, Dellinger RW, Zhong Q, Sun D, Amin S, Spratt TE, et al. Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene. Drug Metab Dispos. 2009;37(10):1999–2007.PubMedCentralPubMedCrossRef
21.
Silva MJ, Reidy JA, Preau JL, Samandar E, Needham LL, Calafat AM. Measurement of eight urinary metabolites of di(2-ethylhexyl)phthalate as biomarkers for human exposure assessment. Biomarkers. 2006;11(1):1–13.PubMedCrossRef
22.
Japan Ministry of Health, Labour and Welfare. Advisory Committee on Health Effects of Endocrine Disruptors. 2005.
23.
Albro PW. Absorption, metabolism, and excretion of di(2-ethylhexyl)phthalate by rats and mice. Environ Health Perspect. 1986;65:293–8.PubMedCentralPubMed
24.
Colacino JA, Harris TR, Schecter A. Dietary intake is associated with phthalate body burden in a nationally representative sample. Environ Health Perspect. 2010;118(7):998–1003.PubMedCentralPubMedCrossRef
25.
Dourson ML, Felter SP, Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol. 1996;24(2 Pt 1):108–20.PubMedCrossRef
26.
Wynne HA, Wood P, Herd B, Wright P, Rawlins MD, James OF. The association of age with the activity of alcohol dehydrogenase in human liver. Age Ageing. 1992;21(6):417–20.PubMedCrossRef
27.
Matsumoto M, Yokoyama H, Shiraishi H, Suzuki H, Kato S, Miura S, et al. Alcohol dehydrogenase activities in the human gastric mucosa: effects of Helicobacter pylori infection, sex, age, and the part of the stomach. Alcohol Clin Exp Res. 2001;25[6 Suppl]:29S–34S.PubMedCrossRef
Metadata
Title
Species and inter-individual differences in metabolic capacity of di(2-ethylhexyl)phthalate (DEHP) between human and mouse livers
Authors
Yuki Ito
Michihiro Kamijima
Chie Hasegawa
Masahiro Tagawa
Toshio Kawai
Mio Miyake
Yumi Hayashi
Hisao Naito
Tamie Nakajima
Publication date
01-03-2014
Publisher
Springer Japan
Published in
Environmental Health and Preventive Medicine / Issue 2/2014
Print ISSN: 1342-078X
Electronic ISSN: 1347-4715
DOI
https://doi.org/10.1007/s12199-013-0362-6

Other articles of this Issue 2/2014

Environmental Health and Preventive Medicine 2/2014 Go to the issue

Regular Article

Respiratory involvements among women exposed to the smoke of traditional biomass fuel and gas fuel in a district of Bangladesh

Review

Review of health hazards and prevention measures for response and recovery workers and volunteers after natural disasters, flooding, and water damage: mold and dampness

Erratum

Erratum to: Arsenic contamination in groundwater and its effects on adolescent intelligence and social competence in Bangladesh with special reference to daily drinking/cooking water intake

Short Communication

Association between PM2.5 and primary care visits due to asthma attack in Japan: relation to Beijing’s air pollution episode in January 2013

Regular Article

Personal hygiene among military personnel: developing and testing a self-administered scale

Regular Article

Arsenic contamination in groundwater and its effects on adolescent intelligence and social competence in Bangladesh with special reference to daily drinking/cooking water intake